ProPhase Labs, Inc. Comprehensive Income
ProPhase Labs, Inc. (PRPH) reported Comprehensive Income of -$3.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-19
- ProPhase Labs, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$3.05M.
- ProPhase Labs, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$7.40M.
- ProPhase Labs, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$6.84M.
- ProPhase Labs, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-06-30 was -$4.47M.
- ProPhase Labs, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$14.74M.
- ProPhase Labs, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$53.26M.
- ProPhase Labs, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$17.84M, a 191.98% decline from fiscal 2022.
- ProPhase Labs, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $19.39M, a 217.48% increase from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.05M 10-Q · filed 2026-08-19 | -$8.23M 10-Q · filed 2026-08-19 | |||||
| 2025-12-31 | -$7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | -$14.24M derived: sum of 2 quarters · filed 2026-06-01 | -$18.71M derived: sum of 3 quarters · filed 2026-08-19 | -$14.74M 10-K · filed 2026-06-01 | |||
| 2025-09-30 | -$6.84M 10-Q · filed 2025-11-19 | -$11.31M derived: sum of 2 quarters · filed 2026-08-19 | -$7.34M 10-Q · filed 2025-11-19 | -$41.70M derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2025-06-30 | -$4.47M 10-Q · filed 2026-08-19 | -$504.00K 10-Q · filed 2026-08-19 | -$34.86M derived: sum of 3 quarters · filed 2026-08-19 | -$41.45M derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2025-03-31 | $3.97M 10-Q · filed 2025-05-20 | -$30.39M derived: sum of 2 quarters · filed 2026-06-01 | -$36.98M derived: sum of 3 quarters · filed 2026-06-01 | -$43.19M derived: sum of 4 quarters · filed 2026-06-01 | |||
| 2024-12-31 | -$34.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | -$40.95M derived: sum of 2 quarters · filed 2026-06-01 | -$47.16M derived: sum of 3 quarters · filed 2026-06-01 | -$53.26M 10-K · filed 2026-06-01 | |||
| 2024-09-30 | -$6.59M 10-Q · filed 2025-11-19 | -$12.80M derived: sum of 2 quarters · filed 2025-11-19 | -$18.90M 10-Q · filed 2025-11-19 | -$26.51M derived: sum of 4 quarters · filed 2025-11-19 | |||
| 2024-06-30 | -$6.21M 10-Q · filed 2025-08-13 | -$12.32M 10-Q · filed 2025-08-13 | -$19.92M derived: sum of 3 quarters · filed 2025-08-13 | -$27.10M derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | -$6.11M 10-Q · filed 2025-05-20 | -$13.71M derived: sum of 2 quarters · filed 2025-05-20 | -$20.89M derived: sum of 3 quarters · filed 2025-05-20 | -$23.83M derived: sum of 4 quarters · filed 2025-05-20 | |||
| 2023-12-31 | -$7.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | -$14.78M derived: sum of 2 quarters · filed 2025-04-01 | -$17.72M derived: sum of 3 quarters · filed 2025-04-01 | -$17.84M 10-K · filed 2025-04-01 | |||
| 2023-09-30 | -$7.17M 10-Q · filed 2024-11-13 | -$10.12M derived: sum of 2 quarters · filed 2024-11-13 | -$10.23M 10-Q · filed 2024-11-13 | -$11.63M derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | -$2.94M 10-Q · filed 2024-08-14 | -$3.06M 10-Q · filed 2024-08-14 | -$4.46M derived: sum of 3 quarters · filed 2024-08-14 | -$3.54M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$115.00K 10-Q · filed 2024-05-10 | -$1.51M derived: sum of 2 quarters · filed 2024-05-10 | -$598.00K derived: sum of 3 quarters · filed 2024-05-10 | $6.75M derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$483.00K derived: sum of 2 quarters · filed 2024-03-29 | $6.87M derived: sum of 3 quarters · filed 2024-03-29 | $19.39M 10-K · filed 2024-03-29 | |||
| 2022-09-30 | $917.00K 10-Q · filed 2023-11-13 | $8.27M derived: sum of 2 quarters · filed 2023-11-13 | $20.80M 10-Q · filed 2023-11-13 | $31.33M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $7.35M 10-Q · filed 2023-08-11 | $19.88M 10-Q · filed 2023-08-11 | $30.41M derived: sum of 3 quarters · filed 2023-08-11 | $26.40M derived: sum of 4 quarters · filed 2023-08-11 | |||
| 2022-03-31 | $12.53M 10-Q · filed 2023-05-12 | $23.07M derived: sum of 2 quarters · filed 2023-05-12 | $19.06M derived: sum of 3 quarters · filed 2023-05-12 | $17.59M derived: sum of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | $10.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $6.53M derived: sum of 2 quarters · filed 2023-03-29 | $5.06M derived: sum of 3 quarters · filed 2023-03-29 | $6.11M 10-K · filed 2023-03-29 | |||
| 2021-09-30 | -$4.01M 10-Q · filed 2022-11-10 | -$5.47M derived: sum of 2 quarters · filed 2022-11-10 | -$4.43M 10-Q · filed 2022-11-10 | -$5.41M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | -$1.46M 10-Q · filed 2022-08-12 | -$416.00K 10-Q · filed 2022-08-12 | -$1.40M derived: sum of 3 quarters · filed 2022-08-12 | -$1.82M derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2021-03-31 | $1.05M 10-Q · filed 2022-05-13 | $61.00K derived: sum of 2 quarters · filed 2022-05-13 | -$355.00K derived: sum of 3 quarters · filed 2022-05-13 | -$290.00K derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | -$985.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$1.40M derived: sum of 2 quarters · filed 2022-03-31 | -$1.34M derived: sum of 3 quarters · filed 2022-03-31 | -$2.13M 10-K · filed 2022-03-31 | |||
| 2020-09-30 | -$416.00K 10-Q · filed 2021-11-12 | -$351.00K derived: sum of 2 quarters · filed 2021-11-12 | -$1.15M 10-Q · filed 2021-11-12 | -$1.61M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $65.00K 10-Q · filed 2021-08-13 | -$733.00K 10-Q · filed 2021-08-13 | -$1.20M derived: sum of 3 quarters · filed 2021-08-13 | -$1.63M derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | -$798.00K 10-Q · filed 2021-05-14 | -$1.26M derived: sum of 2 quarters · filed 2021-05-14 | -$1.69M derived: sum of 3 quarters · filed 2021-05-14 | -$2.92M derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2019-12-31 | -$463.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$896.00K derived: sum of 2 quarters · filed 2021-03-31 | -$2.13M derived: sum of 3 quarters · filed 2021-03-31 | -$3.12M 10-K · filed 2021-03-31 | |||
| 2019-09-30 | -$433.00K 10-Q · filed 2020-11-19 | -$1.66M derived: sum of 2 quarters · filed 2020-11-19 | -$2.66M 10-Q · filed 2020-11-19 | -$3.13M derived: sum of 4 quarters · filed 2020-11-19 | |||
| 2019-06-30 | -$1.23M 10-Q · filed 2020-08-11 | -$2.23M 10-Q · filed 2020-08-11 | -$2.69M derived: sum of 3 quarters · filed 2020-08-11 | -$3.72M derived: sum of 4 quarters · filed 2020-08-11 | |||
| 2019-03-31 | -$998.00K 10-Q · filed 2020-05-12 | -$1.47M derived: sum of 2 quarters · filed 2020-05-12 | -$2.49M derived: sum of 3 quarters · filed 2020-05-12 | -$2.69M derived: sum of 4 quarters · filed 2020-05-12 | |||
| 2018-12-31 | -$467.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$1.50M derived: sum of 2 quarters · filed 2020-03-26 | -$1.69M derived: sum of 3 quarters · filed 2020-03-26 | -$1.69M 10-K · filed 2020-03-26 | |||
| 2018-09-30 | -$1.03M 10-Q · filed 2019-11-12 | -$1.22M derived: sum of 2 quarters · filed 2019-11-12 | -$1.22M 10-Q · filed 2019-11-12 | -$1.48M derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | -$191.00K 10-Q · filed 2019-08-12 | -$192.00K 10-Q · filed 2018-08-20 | -$191.00K 10-Q · filed 2019-08-12 | -$450.00K derived: sum of 3 quarters · filed 2019-08-12 | -$1.26M derived: sum of 4 quarters · filed 2019-08-12 | ||
| 2018-03-31 | $0.00 10-Q/A · filed 2018-08-20 | -$259.00K derived: sum of 2 quarters · filed 2019-03-26 | -$1.07M derived: sum of 3 quarters · filed 2019-03-26 | -$3.38M derived: sum of 4 quarters · filed 2019-03-26 | |||
| 2017-12-31 | -$259.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$1.07M derived: sum of 2 quarters · filed 2019-03-26 | -$3.38M derived: sum of 3 quarters · filed 2019-03-26 | $40.51M 10-K · filed 2019-03-26 | $41.75M 10-K · filed 2018-03-28 | ||
| 2017-09-30 | -$812.00K 10-Q · filed 2018-11-14 | -$3.12M derived: sum of 2 quarters · filed 2018-11-14 | $40.77M 10-Q · filed 2018-11-14 | $41.52M 10-Q · filed 2017-11-13 | $40.20M derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2017-06-30 | -$2.31M 10-Q · filed 2018-08-20 | $41.58M 10-Q · filed 2018-08-20 | $41.01M derived: sum of 3 quarters · filed 2018-08-20 | $41.18M derived: sum of 4 quarters · filed 2018-08-20 | |||
| 2017-03-31 | $43.89M 10-Q/A · filed 2018-08-20 | $44.64M 10-Q · filed 2018-05-15 | $43.32M derived: sum of 2 quarters · filed 2018-08-20 | $43.48M derived: sum of 3 quarters · filed 2018-08-20 | |||
| 2016-12-31 | -$572.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-08-20 | -$405.00K derived: sum of 2 quarters · filed 2018-08-20 | -$2.87M 10-K/A · filed 2018-08-20 | ||||
| 2016-09-30 | $167.00K 10-Q/A · filed 2018-08-20 | -$2.30M 10-Q/A · filed 2018-08-20 | |||||
| 2015-12-31 | -$3.60M 10-K/A · filed 2018-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |